Literature DB >> 28857631

Practical implications of using real-world evidence (RWE) in comparative effectiveness research: learnings from IMI-GetReal.

Amr Makady1,2, Heather Stegenga3, Antonio Ciaglia4, Thomas Pa Debray5,6, Michael Lees7, Michael Happich8, Bettina Ryll9,10, Keith Abrams11, Rob Thwaites12, Sarah Garner3, Páll Jonsson3, Wim Goettsch1,2.   

Abstract

In light of increasing attention towards the use of real-world evidence (RWE) in decision making in recent years, this commentary aims to reflect on the experiences gained in accessing and using RWE for comparative effectiveness research as a part of the Innovative Medicines Initiative GetReal Consortium and discuss their implications for RWE use in decision-making.

Keywords:  comparative effectiveness research; health technology assessment; non-randomized trials; real-world evidence

Mesh：

Year:  2017        PMID： 28857631     DOI： 10.2217/cer-2017-0044

Source DB:  PubMed          Journal:  J Comp Eff Res        ISSN： 2042-6305            Impact factor:   1.744


  8 in total

1.  The European Innovative Medicines Initiative: Progress to Date.

Authors:  Jean-Emmanuel Faure; Tomasz Dyląg; Irene Norstedt; Line Matthiessen
Journal:  Pharmaceut Med       Date:  2018-07-19

Review 2.  The Innovative Medicines Initiative -10 Years of Public-Private Collaboration.

Authors:  Hugh Laverty; Pierre Meulien
Journal:  Front Med (Lausanne)       Date:  2019-12-03

3.  RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design.

Authors:  Andrew D Xia; Caroline P Schaefer; Agota Szende; Elke Jahn; Matthew J Hirst
Journal:  Drugs Real World Outcomes       Date:  2019-12

4.  Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.

Authors:  Kelvin Chan; Seungree Nam; Bill Evans; Claire de Oliveira; Alexandra Chambers; Scott Gavura; Jeffrey Hoch; Rebecca E Mercer; Wei Fang Dai; Jaclyn Beca; Mina Tadrous; Wanrudee Isaranuwatchai
Journal:  BMJ Open       Date:  2020-01-07       Impact factor: 2.692

5.  Methods for the inclusion of real-world evidence in network meta-analysis.

Authors:  David A Jenkins; Humaira Hussein; Reynaldo Martina; Pascale Dequen-O'Byrne; Keith R Abrams; Sylwia Bujkiewicz
Journal:  BMC Med Res Methodol       Date:  2021-10-09       Impact factor: 4.615

6.  Real World Data in Health Technology Assessment of Complex Health Technologies.

Authors:  Milou A Hogervorst; Johan Pontén; Rick A Vreman; Aukje K Mantel-Teeuwisse; Wim G Goettsch
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

7.  Network Meta-analysis on Disconnected Evidence Networks When Only Aggregate Data Are Available: Modified Methods to Include Disconnected Trials and Single-Arm Studies while Minimizing Bias.

Authors:  Howard Thom; Joy Leahy; Jeroen P Jansen
Journal:  Med Decis Making       Date:  2022-05-07       Impact factor: 2.749

Review 8.  Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of Simplifying Assumptions.

Authors:  Ruth A Lewis; Dyfrig Hughes; Alex J Sutton; Clare Wilkinson
Journal:  Pharmacoeconomics       Date:  2020-11-26       Impact factor: 4.981
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.